Skip to main content
Full access
Letters to the Editor
Published Online: 1 December 2020

Are All Psychotic-Like Experiences Really “Psychotic”?

To the Editor: The robust and enlightening longitudinal study by Rimvall et al. (1), published in the April 2020 issue of the Journal, demonstrated that children with “psychotic experiences,” as measured by the Schedule for Affective Disorders and Schizophrenia for School-Age Children–Present and Lifetime Version (K-SADS-PL), at age 11 were three times more likely to receive psychotropic medication or be diagnosed with neurodevelopmental or emotional disorders (though not psychotic disorders) within 5 years compared with children without these experiences. We understand the authors to mean that there are certain forms of experience that, as the authors write, are “common in childhood” and “within the range of normal development” that can predict future nonpsychotic diagnoses and indicate a “transdiagnostic vulnerability for diagnosed psychopathology.” However, there are some questions about the phenomenological nature of these experiences, which we now consider.
If a form of experience is both common and developmentally normal, how can it be thought to be an indicator for “underlying vulnerability … of psychopathology”? This suggests a logical difficulty. Surely any indicator for the developmentally nonnormal ought not itself be deemed developmentally normal; to do so would suggest a violation of noncontradiction. Only if phenomena captured under “psychotic experiences” are heterogenous can we reasonably say that some are within the range of normal development while others are aberrant and portend pathological outcomes.
We submit that “psychotic-like experiences” suggest distress but that “different [psychotic-like experience] subtypes appear to be maladaptive in different ways and to indicate varying levels of risk of psychosis and other severe mental disorders[;] it is, we believe, misleading to define [psychotic-like experiences] as a homogenous entity” (2).
This is probably one reason for the immense difficulty in parsing the literature showing different prevalences of psychotic experiences by ethnicity, even given socioeconomic findings. We suggest that psychotic-like experiences are mediated by various biological, cultural, cognitive, and hermeneutic means, which would make them phenomenologically and physiologically disparate.
The final consideration is methodological. The assessment used to screen for psychotic experiences appears to have been an early version of the K-SADS-PL, with initial reliability and validity data cited (3). However, in that validation study, active psychosis was an exclusion criterion, and psychotic experiences were not reported. Lastly, newer, expanded versions of the K-SADS-PL may yield different results given the detailed expansion of the psychosis section.
In summary, we suggest that:
 1. Common and developmentally normal experiences cannot, by definition, be indicative of underlying diatheses for psychopathology.
 2. Psychotic-like experiences can constitute nonspecific, heterogenous markers of distress.
 3. The content and discriminant validity of the K-SADS-PL for psychotic symptom constructs must be shown to assert confidently the facticity of psychotic experiences. The same is true for the newer version of the instrument, as well.

References

1.
Rimvall MK, van Os J, Verhulst F, et al: Mental health service use and psychopharmacological treatment following psychotic experiences in preadolescence. Am J Psychiatry 2020; 177:318–326
2.
Armando M, Nelson B, Yung AR, et al: Psychotic-like experiences and correlation with distress and depressive symptoms in a community sample of adolescents and young adults. Schizophr Res 2010; 119:258–265
3.
Kaufman J, Birmaher B, Brent D, et al: Schedule for Affective Disorders and Schizophrenia for School-Age Children–Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36:980–988

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1179

History

Accepted: 27 May 2020
Published online: 1 December 2020
Published in print: December 01, 2020

Keywords

  1. Research Design and Methods
  2. Child/Adolescent Psychiatry
  3. Assessment and Interviewing
  4. Schizophrenia Spectrum and Other Psychotic Disorders
  5. Psychotic Experiences

Authors

Affiliations

Donald McLawhorn, M.D., Ph.D.
Department of Psychiatry, State University of New York, Upstate Medical University, Syracuse.
Daniel Jackson, M.D. [email protected]
Department of Psychiatry, State University of New York, Upstate Medical University, Syracuse.

Notes

Send correspondence to Dr. Jackson ([email protected]).

Funding Information

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share